Cargando…

Ethanol Sclerotherapy versus Laparoscopic Surgery in Management of Ovarian Endometrioma; a Randomized Clinical Trial

INTRODUCTION: A variety of therapeutic modalities are available in management of ovarian endometrioma. This study aimed to compare the effects of ethanol sclerotherapy and laparoscopic surgery on disease recurrence and ovarian factors of these patients. METHODS: 70 women with ovarian endometrioma an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghasemi Tehrani, Hatav, Tavakoli, Raheleh, Hashemi, Maryam, Haghighat, Somayeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shahid Beheshti University of Medical Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397592/
https://www.ncbi.nlm.nih.gov/pubmed/36033993
http://dx.doi.org/10.22037/aaem.v10i1.1636
_version_ 1784772154425868288
author Ghasemi Tehrani, Hatav
Tavakoli, Raheleh
Hashemi, Maryam
Haghighat, Somayeh
author_facet Ghasemi Tehrani, Hatav
Tavakoli, Raheleh
Hashemi, Maryam
Haghighat, Somayeh
author_sort Ghasemi Tehrani, Hatav
collection PubMed
description INTRODUCTION: A variety of therapeutic modalities are available in management of ovarian endometrioma. This study aimed to compare the effects of ethanol sclerotherapy and laparoscopic surgery on disease recurrence and ovarian factors of these patients. METHODS: 70 women with ovarian endometrioma and chronic pelvic pain were randomly divided into two groups. The first group underwent sclerotherapy with a puncture needle (cook) and the second group underwent laparoscopic surgery. Both groups were followed up every three months to investigate the recurrence rate. In this regard, ultrasonography was performed 3 months and 12 months after treatment, and serum anti-Müllerian hormone (AMH) levels were also reassessed 12 weeks after the intervention. RESULTS: 70 women with the mean age of 31.46 ± 4.71 years, and the mean body mass index (BMI) of 23.12 ± 1.01 were studied. The two groups were similar regarding age (p = 0.770), BMI (p = 0.371), history of gastrointestinal signs (p = 0.794), history of urinary diseases (p = 0.324), dysmenorrhea (p = 0.403), pelvic pain (p = 0.454), dyspareunia (p = 0.448), location of cyst (p = 0.448), and diameter of cyst (p = 0.250). In the laparoscopic group, a significant decrease in anti-Müllerian hormone (AMH) levels was observed after 12 weeks (p < 0.0001), while in the sclerotherapy group, no significant changes were found between pre-and post-operative AMH levels (p = 0.120). Cyst size decreased significantly in both groups three months (p < 0.001) and twelve months (p < 0.0001) after treatment. In the third month, 8 patients in the sclerotherapy group and 13 patients in the laparoscopic group had recurrences, and in the twelfth month, 17 patients in the sclerotherapy group and 15 patients in the laparoscopic group had recurrence of symptoms (p > 0.05). CONCLUSIONS: Although AMH level and mean cyst diameter were significantly lower one year after laparoscopy, recurrence rate of ovarian endometrioma was similar between ethanol sclerotherapy and laparoscopy methods.
format Online
Article
Text
id pubmed-9397592
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Shahid Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-93975922022-08-26 Ethanol Sclerotherapy versus Laparoscopic Surgery in Management of Ovarian Endometrioma; a Randomized Clinical Trial Ghasemi Tehrani, Hatav Tavakoli, Raheleh Hashemi, Maryam Haghighat, Somayeh Arch Acad Emerg Med Original Article INTRODUCTION: A variety of therapeutic modalities are available in management of ovarian endometrioma. This study aimed to compare the effects of ethanol sclerotherapy and laparoscopic surgery on disease recurrence and ovarian factors of these patients. METHODS: 70 women with ovarian endometrioma and chronic pelvic pain were randomly divided into two groups. The first group underwent sclerotherapy with a puncture needle (cook) and the second group underwent laparoscopic surgery. Both groups were followed up every three months to investigate the recurrence rate. In this regard, ultrasonography was performed 3 months and 12 months after treatment, and serum anti-Müllerian hormone (AMH) levels were also reassessed 12 weeks after the intervention. RESULTS: 70 women with the mean age of 31.46 ± 4.71 years, and the mean body mass index (BMI) of 23.12 ± 1.01 were studied. The two groups were similar regarding age (p = 0.770), BMI (p = 0.371), history of gastrointestinal signs (p = 0.794), history of urinary diseases (p = 0.324), dysmenorrhea (p = 0.403), pelvic pain (p = 0.454), dyspareunia (p = 0.448), location of cyst (p = 0.448), and diameter of cyst (p = 0.250). In the laparoscopic group, a significant decrease in anti-Müllerian hormone (AMH) levels was observed after 12 weeks (p < 0.0001), while in the sclerotherapy group, no significant changes were found between pre-and post-operative AMH levels (p = 0.120). Cyst size decreased significantly in both groups three months (p < 0.001) and twelve months (p < 0.0001) after treatment. In the third month, 8 patients in the sclerotherapy group and 13 patients in the laparoscopic group had recurrences, and in the twelfth month, 17 patients in the sclerotherapy group and 15 patients in the laparoscopic group had recurrence of symptoms (p > 0.05). CONCLUSIONS: Although AMH level and mean cyst diameter were significantly lower one year after laparoscopy, recurrence rate of ovarian endometrioma was similar between ethanol sclerotherapy and laparoscopy methods. Shahid Beheshti University of Medical Sciences 2022-07-07 /pmc/articles/PMC9397592/ /pubmed/36033993 http://dx.doi.org/10.22037/aaem.v10i1.1636 Text en https://creativecommons.org/licenses/by-nc/3.0/This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0) https://creativecommons.org/licenses/by-nc/3.0/.
spellingShingle Original Article
Ghasemi Tehrani, Hatav
Tavakoli, Raheleh
Hashemi, Maryam
Haghighat, Somayeh
Ethanol Sclerotherapy versus Laparoscopic Surgery in Management of Ovarian Endometrioma; a Randomized Clinical Trial
title Ethanol Sclerotherapy versus Laparoscopic Surgery in Management of Ovarian Endometrioma; a Randomized Clinical Trial
title_full Ethanol Sclerotherapy versus Laparoscopic Surgery in Management of Ovarian Endometrioma; a Randomized Clinical Trial
title_fullStr Ethanol Sclerotherapy versus Laparoscopic Surgery in Management of Ovarian Endometrioma; a Randomized Clinical Trial
title_full_unstemmed Ethanol Sclerotherapy versus Laparoscopic Surgery in Management of Ovarian Endometrioma; a Randomized Clinical Trial
title_short Ethanol Sclerotherapy versus Laparoscopic Surgery in Management of Ovarian Endometrioma; a Randomized Clinical Trial
title_sort ethanol sclerotherapy versus laparoscopic surgery in management of ovarian endometrioma; a randomized clinical trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397592/
https://www.ncbi.nlm.nih.gov/pubmed/36033993
http://dx.doi.org/10.22037/aaem.v10i1.1636
work_keys_str_mv AT ghasemitehranihatav ethanolsclerotherapyversuslaparoscopicsurgeryinmanagementofovarianendometriomaarandomizedclinicaltrial
AT tavakoliraheleh ethanolsclerotherapyversuslaparoscopicsurgeryinmanagementofovarianendometriomaarandomizedclinicaltrial
AT hashemimaryam ethanolsclerotherapyversuslaparoscopicsurgeryinmanagementofovarianendometriomaarandomizedclinicaltrial
AT haghighatsomayeh ethanolsclerotherapyversuslaparoscopicsurgeryinmanagementofovarianendometriomaarandomizedclinicaltrial